STOCK TITAN

[SCHEDULE 13G/A] Twist Bioscience Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Artisan Partners group reported beneficial ownership of 6,410,900 shares of Twist Bioscience Corporation common stock, representing 10.6% of the outstanding class based on 07/30/2025 share count. The filing shows no sole voting or dispositive power; instead the filers report shared voting power of 5,303,412 shares and shared dispositive power of 6,410,900. The shares are held for discretionary clients of Artisan Partners Limited Partnership and, according to the certification, were acquired in the ordinary course of business and not with the purpose of changing control. The report is filed as a joint Schedule 13G amendment and includes a joint filing agreement signed on 10/07/2025.

Il gruppo Artisan Partners ha riportato la proprietà beneficia di 6.410.900 azioni delle azioni ordinarie di Twist Bioscience Corporation, che rappresentano 10,6% della classe in circolazione, basata sul conteggio azionario del 07/30/2025. La pratica non mostra alcun potere di voto o dispositiva esclusivo; invece, i presentatori riportano potere di voto condiviso di 5.303.412 azioni e potere dispositiva condiviso di 6.410.900. Le azioni sono detenute per conto di clienti discrezionali del Artisan Partners Limited Partnership e, secondo la certificazione, sono state acquisite nel normale svolgimento dell'attività e non con lo scopo di cambiare il controllo. Il rapporto è presentato come una modifica congiunta Schedule 13G e include un accordo di deposito congiunto firmato il 10/07/2025.

El grupo Artisan Partners informó titularidad beneficiosa de 6.410.900 acciones de las acciones comunes de Twist Bioscience Corporation, que representan 10.6% de la clase en circulación según el recuento de acciones al 07/30/2025. El expediente no muestra poder de voto o dispositiva exclusivo; en su lugar, los presentantes reportan poder de voto compartido de 5.303.412 acciones y poder dispositivo compartido de 6.410.900. Las acciones se mantienen para clientes discrenionales de Artisan Partners Limited Partnership y, según la certificación, se adquirieron en el curso normal de negocios y no con la finalidad de cambiar el control. El informe se presenta como una enmienda conjunta del Schedule 13G e incluye un acuerdo de presentación conjunta firmado el 10/07/2025.

아티즌 파트너스 그룹은 Twist Bioscience Corporation 보통주 6,410,900주에 대한 유리한 소유 지분을 보고했고, 이는 10.6%에 해당하며 07/30/2025의 발행 주식 수를 기준으로 한다. 신고서는 단독 의결권이나 처분권을 보여주지 않으며, 대신 제출자들은 공동 의결권 5,303,412주공동 처분권 6,410,900주을 보고한다. 이 주식은 Artisan Partners Limited Partnership의 재량 고객을 위해 보유되었으며, 인증에 따르면 정상적인 업무 과정에서 취득되었고 지배권 변경 목적은 없다고 한다. 이 보고서는 Schedule 13G의 공동 수정으로 제출되며 10/07/2025에 서명된 공동 제출 동의서를 포함한다.

Le groupe Artisan Partners a déclaré une détention bénéficiaire de 6 410 900 actions des actions ordinaires de Twist Bioscience Corporation, représentant 10,6% de la catégorie en circulation selon le décompte des actions au 07/30/2025. Le dossier ne montre aucun pouvoir de vote ou de disposition exclusif; les déposants indiquent plutôt un pouvoir de vote partagé de 5 303 412 actions et un pouvoir de disposition partagé de 6 410 900. Ces actions sont détenues pour le compte de clients discrétionnaires de Artisan Partners Limited Partnership et, selon la certification, ont été acquises dans le cours normal des affaires et non dans le but de modifier le contrôle. Le rapport est déposé comme un amendement conjoint Schedule 13G et inclut un accord de dépôt conjoint signé le 10/07/2025.

Die Artisan Partners-Gruppe meldete eine wohltätige Eigentümerschaft an 6.410.900 Aktien der Twist Bioscience Corporation Stammaktien, die 10,6% der ausstehenden Klasse gemäß der Aktienanzahl vom 07/30/2025 darstellen. Die Einreichung zeigt kein alleiniges Stimm- oder Verfügungsmacht; stattdessen melden die Einreicher geteilte Stimmmacht von 5.303.412 Aktien und geteilte Verfügungsmacht von 6.410.900. Die Aktien werden für treuhänderische Kunden von Artisan Partners Limited Partnership gehalten und laut Zertifizierung im normalen Geschäftsgang erworben und nicht mit dem Zweck der Veränderung der Kontrolle. Der Bericht wird als gemeinsame Schedule 13G-Änderung eingereicht und enthält eine gemeinsame Einreichungsvereinbarung, unterschrieben am 10/07/2025.

أفادت مجموعة Artisan Partners بامتلاك ذي فائدة من 6,410,900 سهماً من أسهم Twist Bioscience Corporation العادية، تمثل 10.6% من الفئة القائمة استناداً إلى عدد الأسهم في 07/30/2025. لا يظهر الطلب أي سلطة تصويت منفردة أو سلطة تصرف منفردة؛ وبدلاً من ذلك يُذكر المقدمون سلطة التصويت المشتركة البالغة 5,303,412 سهماً و سلطة التصرف المشتركة البالغة 6,410,900. وتُحتفظ الأسهم لعملاء مقيدين من Artisan Partners Limited Partnership، ووفقاً للشهادة، فُتكتسبت في إطار الأعمال الاعتيادية وليس بهدف تغيير السيطرة. يتم تقديم التقرير كنسخة Schedule 13G مشتركة ويتضمن اتفاق تقديم مشترك موقع في 10/07/2025.

Artisan Partners 集团披露对 Twist Bioscience Corporation 普通股拥有6,410,900股的受益所有权,代表截至2025-07-30的在外流通股本的10.6% 申报中未显示单独的表决权或处置权;相反,申报人报告共有投票权为5,303,412股,以及共有处置权为6,410,900股。该等股份为 Artisan Partners Limited Partnership 的自由裁量客户所持,且据认证所述,是在正常业务过程中取得,且并非以改变控制为目的。本报告作为联合 Schedule 13G 修订提交,并包含于 2025-10-07 签署的联合提交协议。

Positive
  • Disclosure of a sizeable passive stake of 6,410,900 shares (10.6%), improving transparency for investors
  • Certification of ordinary-course acquisition reduces immediate regulatory concerns about control intent
Negative
  • Concentrated ownership at 10.6% increases susceptibility to large rebalancing by the adviser
  • No sole voting power reported, which may limit predictable engagement or support in contested matters

Insights

Large passive stake disclosed; shared control, not an activist move.

The group reports 6,410,900 shares, equal to 10.6% of the class, held for discretionary clients under shared voting and dispositive arrangements. That size crosses common 5% disclosure and is material to shareholder base concentration.

Risks and dependencies include client redemptions or portfolio rebalancing that could change holdings; there is no stated intent to influence control and the certification affirms ordinary-course acquisition. Watch holdings in subsequent filings and any Schedule 13D that would indicate a strategic change within a typical regulatory window.

Shared voting power implies collective decision-making across Artisan entities.

The report shows 5,303,412 shares with shared voting power and full shared dispositive power over 6,410,900 shares, reflecting the intertwined structure of Artisan Partners entities disclosed in the filing. This structure centralizes stewardship while identifying multiple filing entities.

Monitor any proxy-related communications or changes in voting alignments ahead of annual meetings or material corporate actions; changes in the voting share count would be the clearest near-term signal of altered governance influence.

Il gruppo Artisan Partners ha riportato la proprietà beneficia di 6.410.900 azioni delle azioni ordinarie di Twist Bioscience Corporation, che rappresentano 10,6% della classe in circolazione, basata sul conteggio azionario del 07/30/2025. La pratica non mostra alcun potere di voto o dispositiva esclusivo; invece, i presentatori riportano potere di voto condiviso di 5.303.412 azioni e potere dispositiva condiviso di 6.410.900. Le azioni sono detenute per conto di clienti discrezionali del Artisan Partners Limited Partnership e, secondo la certificazione, sono state acquisite nel normale svolgimento dell'attività e non con lo scopo di cambiare il controllo. Il rapporto è presentato come una modifica congiunta Schedule 13G e include un accordo di deposito congiunto firmato il 10/07/2025.

El grupo Artisan Partners informó titularidad beneficiosa de 6.410.900 acciones de las acciones comunes de Twist Bioscience Corporation, que representan 10.6% de la clase en circulación según el recuento de acciones al 07/30/2025. El expediente no muestra poder de voto o dispositiva exclusivo; en su lugar, los presentantes reportan poder de voto compartido de 5.303.412 acciones y poder dispositivo compartido de 6.410.900. Las acciones se mantienen para clientes discrenionales de Artisan Partners Limited Partnership y, según la certificación, se adquirieron en el curso normal de negocios y no con la finalidad de cambiar el control. El informe se presenta como una enmienda conjunta del Schedule 13G e incluye un acuerdo de presentación conjunta firmado el 10/07/2025.

아티즌 파트너스 그룹은 Twist Bioscience Corporation 보통주 6,410,900주에 대한 유리한 소유 지분을 보고했고, 이는 10.6%에 해당하며 07/30/2025의 발행 주식 수를 기준으로 한다. 신고서는 단독 의결권이나 처분권을 보여주지 않으며, 대신 제출자들은 공동 의결권 5,303,412주공동 처분권 6,410,900주을 보고한다. 이 주식은 Artisan Partners Limited Partnership의 재량 고객을 위해 보유되었으며, 인증에 따르면 정상적인 업무 과정에서 취득되었고 지배권 변경 목적은 없다고 한다. 이 보고서는 Schedule 13G의 공동 수정으로 제출되며 10/07/2025에 서명된 공동 제출 동의서를 포함한다.

Le groupe Artisan Partners a déclaré une détention bénéficiaire de 6 410 900 actions des actions ordinaires de Twist Bioscience Corporation, représentant 10,6% de la catégorie en circulation selon le décompte des actions au 07/30/2025. Le dossier ne montre aucun pouvoir de vote ou de disposition exclusif; les déposants indiquent plutôt un pouvoir de vote partagé de 5 303 412 actions et un pouvoir de disposition partagé de 6 410 900. Ces actions sont détenues pour le compte de clients discrétionnaires de Artisan Partners Limited Partnership et, selon la certification, ont été acquises dans le cours normal des affaires et non dans le but de modifier le contrôle. Le rapport est déposé comme un amendement conjoint Schedule 13G et inclut un accord de dépôt conjoint signé le 10/07/2025.

Die Artisan Partners-Gruppe meldete eine wohltätige Eigentümerschaft an 6.410.900 Aktien der Twist Bioscience Corporation Stammaktien, die 10,6% der ausstehenden Klasse gemäß der Aktienanzahl vom 07/30/2025 darstellen. Die Einreichung zeigt kein alleiniges Stimm- oder Verfügungsmacht; stattdessen melden die Einreicher geteilte Stimmmacht von 5.303.412 Aktien und geteilte Verfügungsmacht von 6.410.900. Die Aktien werden für treuhänderische Kunden von Artisan Partners Limited Partnership gehalten und laut Zertifizierung im normalen Geschäftsgang erworben und nicht mit dem Zweck der Veränderung der Kontrolle. Der Bericht wird als gemeinsame Schedule 13G-Änderung eingereicht und enthält eine gemeinsame Einreichungsvereinbarung, unterschrieben am 10/07/2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G




Comment for Type of Reporting Person: (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G




Comment for Type of Reporting Person: (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G




Comment for Type of Reporting Person: (e) Artisan Partners Limited Partnership is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. (g) Artisan Partners Holdings LP is the sole limited partner of Artisan Partners Limited Partnership and the sole member of Artisan Investments GP LLC; Artisan Investments GP LLC is the general partner of Artisan Partners Limited Partnership; Artisan Partners Asset Management Inc. is the general partner of Artisan Partners Holdings LP.


SCHEDULE 13G



Artisan Partners Asset Management Inc.
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Executive Vice President of Artisan Partners Asset Management Inc.
Date:10/07/2025
Artisan Partners Holdings LP
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Executive Vice President of Artisan Partners Asset Management Inc., as the general partner of Artisan Partners Holdings LP
Date:10/07/2025
Artisan Investments GP LLC
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Vice President of Artisan Investments GP LLC
Date:10/07/2025
Artisan Partners Limited Partnership
Signature:/s/ Gregory K. Ramirez
Name/Title:Gregory K. Ramirez, Vice President of Artisan Investments GP LLC, as the general partner of Artisan Partners Limited Partnership
Date:10/07/2025

Comments accompanying signature: Exhibit Index Exhibit 1 - Joint Filing Agreement dated 10/7/2025 by and among Artisan Partners Asset Management Inc., Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership.

FAQ

What stake in Twist Bioscience (TWST) did Artisan Partners disclose?

Artisan Partners reported beneficial ownership of 6,410,900 shares, representing 10.6% of TWST based on 60,360,925 shares outstanding as of 07/30/2025.

Does Artisan Partners claim control of Twist Bioscience in this filing?

No. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control; no sole voting or dispositive power is reported.

How much voting power does the Artisan group report?

The filers report shared voting power of 5,303,412 shares and shared dispositive power of 6,410,900 shares; sole voting/dispositive power is 0.

On whose behalf are the shares held?

The shares were acquired on behalf of discretionary clients of Artisan Partners Limited Partnership; the filing notes no single client is known to hold an economic interest over 5%.

When was the joint filing agreement signed?

The exhibit lists a Joint Filing Agreement dated 10/07/2025 and the signatures are dated the same day.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.92B
59.19M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO